Remove 2012 Remove Competition Remove Networking
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4

Medicine 116
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Let’s dive into the current state of the pharma industry and learn more about what your team can do to stay ahead of the curve and the competition. Fewer Networking & Industry Trade Show Events. August 23, 2022.

Pharma 52
article thumbnail

Planning for 2023: 10 Advanced Strategies for Marketing & Advertising 

Healthcare Success

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. As you likely already know, Medicare Advantage is growing, and the landscape is becoming more competitive. As a result, many U.S.

article thumbnail

Microbiome innovation: have we forgotten the basics?

European Pharmaceutical Review

This network of trillions of microorganisms residing in our gut and across our body has opened new avenues in medicine, offering the promise of innovative, minimally invasive therapies. This intricate network is vital for maintaining gut health, our immune system, and even mental wellbeing. References Kamada N, Kim YG , Sham HP, et al.

article thumbnail

A Dynamic Journey In Robotics Medical Device Sales With Valerie Davis

Evolve Your Success

We work with the distributor network, unlike some of the bigger companies that have a maybe direct-to-corporation set of reps that are selling. January 2012 is when I started with that. I’m not saying anybody can’t, but they’re sure competitive and doing it immediately out of college. How long ago was this?

Medical 52